Imaging digital arteries in systemic sclerosis by tomographic 3-dimensional ultrasound

被引:0
作者
M. Hughes
S. Rogers
J. Carreira
T. Moore
J. Manning
G. Dinsdale
C. McCollum
A. L. Herrick
机构
[1] The University of Manchester,Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health
[2] Salford Royal NHS Foundation Trust,Manchester Academic Health Science Centre
[3] University of Manchester,Academic Surgery Unit, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre
[4] Wythenshawe Hospital,Department of Rheumatology
[5] Manchester University NHS Foundation Trust,undefined
[6] Independent Vascular Services Ltd,undefined
[7] Wythenshawe Hospital,undefined
[8] Manchester University NHS Foundation Trust,undefined
[9] Royal Hallamshire Hospital,undefined
[10] Sheffield Teaching Hospitals NHS Foundation Trust,undefined
来源
Rheumatology International | 2021年 / 41卷
关键词
Systemic sclerosis; Tomographic three-dimensional (3-d) ultrasound; High-frequency ultrasound; Ultra-high-frequency ultrasound; Total wall volume;
D O I
暂无
中图分类号
学科分类号
摘要
Objective methods are needed to quantify digital artery disease in systemic sclerosis (SSc) for clinical trials of vascular therapies. Our primary aim was to examine feasibility of a novel tomographic three-dimensional-(3-D) ultrasound (tUS) with high-frequency ultrasound (HFUS) or ultra-high-frequency ultrasound (UHFUS) to assess the digital arteries in patients with SSc compared to healthy controls. A secondary objective was to compare the total wall volume (TWV) as a measure of intimal/medial thickness. Eighteen patients with a confirmed diagnosis of SSc were studied by tUS HFUS (17.5 MHz, n = 10) or tUS UHFUS (48 and 70 MHz, n = 8) with equal numbers of healthy controls of similar age and gender. The majority of patients had limited cutaneous SSc and were representative of a spectrum of digital vasculopathy, with over half (n = 6 HFUS and n = 5 UHFUS) having previous digital ulceration. Over half were receiving oral vasodilatory therapy. TWV was measured in both digital arteries of the middle finger bilaterally. At least, two digital arteries could be identified at 17.5 MHz in all patients and healthy controls. Whereas, at least two digital arteries could be identified in relatively fewer patients compared to healthy controls using 48 MHz (n = 6 and 10) and especially 70 MHz (n = 4 and 10) UHFUS. The median difference in TWV between patients and healthy controls was -6.49 mm3 using 17.5 MHz, 1.9 mm3 at 48 MHz, and -0.4 mm3 at 70 MHz. tUS using UHFUS is a feasible method to measure TWV of digital arteries in SSc. Transducer frequency plays an important factor in successful digital artery measurement, with 48 MHz being the optimal frequency.
引用
收藏
页码:1089 / 1096
页数:7
相关论文
共 141 条
[1]  
Denton CP(2017)Systemic sclerosis Lancet 390 1685-1699
[2]  
Khanna DK(2019)Systemic sclerosis Br J Hosp Med 80 530-536
[3]  
Hughes M(2020)Raynaud phenomenon and digital ulcers in systemic sclerosis Nat Rev Rheumatol 16 208-221
[4]  
Herrick AL(2011)Van Doornum S (2011) Cardiovascular disease in systemic sclerosis: an emerging association? Arthritis Res Ther 13 237-2090
[5]  
Hughes M(2011)Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis Arthritis Rheum 63 2078-216
[6]  
Allanore Y(2016)Differential diagnosis of critical digital ischemia in systemic sclerosis: report of five cases and review of the literature Semin Arthritis Rheum 46 209-123
[7]  
Chung L(2008)Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis Ann Rheum Dis 67 120-1164
[8]  
Pauling JD(2006)Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis Br J Dermatol 155 1159-2754
[9]  
Denton CP(2007)Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis Arthritis Rheum 56 2747-1243
[10]  
Matucci-Cerinic M(2008)Micro magnetic resonance angiography of the finger in systemic sclerosis Rheumatol (Oxford) 47 1239-408